POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29 | +38.1% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $21 | -43.2% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $37 | -42.2% | 12,000 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $64 | -99.8% | 12,000 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $42,000 | +35.5% | 12,000 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $31,000 | -42.6% | 12,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $54,000 | -34.1% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $82,000 | -5.7% | 12,000 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $87,000 | -27.5% | 12,000 | 0.0% | 0.01% | -30.0% |
| Q2 2021 | $120,000 | +4.3% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $115,000 | -12.9% | 12,000 | 0.0% | 0.01% | -23.1% |
| Q4 2020 | $132,000 | -17.5% | 12,000 | -33.3% | 0.01% | -23.5% |
| Q3 2020 | $160,000 | – | 18,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $7,605,000 | 1.52% |
| Privium Fund Management (UK) Ltd | 48,470 | $353,000 | 0.38% |
| Pentwater Capital Management LP | 4,967,227 | $36,211,000 | 0.37% |
| J. Goldman & Co LP | 301,391 | $2,197,000 | 0.11% |
| Perceptive Advisors | 787,745 | $5,743,000 | 0.08% |
| KNOTT DAVID M | 29,566 | $216,000 | 0.08% |
| Virtus ETF Advisers LLC | 23,082 | $168,000 | 0.07% |
| Altium Capital Management LP | 32,238 | $235,000 | 0.06% |
| Advisory Services Network, LLC | 268,290 | $1,956,000 | 0.06% |
| MCF Advisors LLC | 66,185 | $482,000 | 0.05% |